Sequence-specific targeting of Drosophila roX genes by the MSL dosage compensation complex

Yongkyu Park, Gabrielle Mengus, Xiaoying Bai, Yuji Kageyama, Victoria H. Meller, Peter B. Becker, Mitzi I. Kuroda

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

MSL complexes bind the single male X chromosome in Drosophila to increase transcription approximately 2-fold. Complexes contain at least five proteins and two noncoding RNAs, roX1 and roX2. The mechanism of X chromosome binding is not known. Here, we identify a 110 bp sequence in roX2 characterized by high-affinity MSL binding, male-specific DNase I hypersensitivity, a shared consensus with the otherwise dissimilar roX1 gene, and conservation across species. Mutagenesis of evolutionarily conserved sequences diminishes MSL binding in vivo. MSL binding to these sites is roX RNA dependent, suggesting that complexes become competent for binding only after incorporation of roX RNAs. However, the roX RNA segments homologous to the DNA binding sites are not required, ruling out simple RNA-DNA complementarity as the primary targeting mechanism. Our results are consistent with a model in which nascent roX RNA assembly with MSL proteins is an early step in the initiation of dosage compensation.

Original languageEnglish (US)
Pages (from-to)977-986
Number of pages10
JournalMolecular Cell
Volume11
Issue number4
DOIs
StatePublished - Apr 1 2003

Fingerprint

Drosophila
RNA
X Chromosome
Binding Sites
Untranslated RNA
Conserved Sequence
Deoxyribonuclease I
DNA
Mutagenesis
Hypersensitivity
Proteins
Genes

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Park, Y., Mengus, G., Bai, X., Kageyama, Y., Meller, V. H., Becker, P. B., & Kuroda, M. I. (2003). Sequence-specific targeting of Drosophila roX genes by the MSL dosage compensation complex. Molecular Cell, 11(4), 977-986. https://doi.org/10.1016/S1097-2765(03)00147-3

Sequence-specific targeting of Drosophila roX genes by the MSL dosage compensation complex. / Park, Yongkyu; Mengus, Gabrielle; Bai, Xiaoying; Kageyama, Yuji; Meller, Victoria H.; Becker, Peter B.; Kuroda, Mitzi I.

In: Molecular Cell, Vol. 11, No. 4, 01.04.2003, p. 977-986.

Research output: Contribution to journalArticle

Park, Y, Mengus, G, Bai, X, Kageyama, Y, Meller, VH, Becker, PB & Kuroda, MI 2003, 'Sequence-specific targeting of Drosophila roX genes by the MSL dosage compensation complex', Molecular Cell, vol. 11, no. 4, pp. 977-986. https://doi.org/10.1016/S1097-2765(03)00147-3
Park, Yongkyu ; Mengus, Gabrielle ; Bai, Xiaoying ; Kageyama, Yuji ; Meller, Victoria H. ; Becker, Peter B. ; Kuroda, Mitzi I. / Sequence-specific targeting of Drosophila roX genes by the MSL dosage compensation complex. In: Molecular Cell. 2003 ; Vol. 11, No. 4. pp. 977-986.
@article{bf4a7e2bc23448f48786964f8b4619c3,
title = "Sequence-specific targeting of Drosophila roX genes by the MSL dosage compensation complex",
abstract = "MSL complexes bind the single male X chromosome in Drosophila to increase transcription approximately 2-fold. Complexes contain at least five proteins and two noncoding RNAs, roX1 and roX2. The mechanism of X chromosome binding is not known. Here, we identify a 110 bp sequence in roX2 characterized by high-affinity MSL binding, male-specific DNase I hypersensitivity, a shared consensus with the otherwise dissimilar roX1 gene, and conservation across species. Mutagenesis of evolutionarily conserved sequences diminishes MSL binding in vivo. MSL binding to these sites is roX RNA dependent, suggesting that complexes become competent for binding only after incorporation of roX RNAs. However, the roX RNA segments homologous to the DNA binding sites are not required, ruling out simple RNA-DNA complementarity as the primary targeting mechanism. Our results are consistent with a model in which nascent roX RNA assembly with MSL proteins is an early step in the initiation of dosage compensation.",
author = "Yongkyu Park and Gabrielle Mengus and Xiaoying Bai and Yuji Kageyama and Meller, {Victoria H.} and Becker, {Peter B.} and Kuroda, {Mitzi I.}",
year = "2003",
month = "4",
day = "1",
doi = "10.1016/S1097-2765(03)00147-3",
language = "English (US)",
volume = "11",
pages = "977--986",
journal = "Molecular Cell",
issn = "1097-2765",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Sequence-specific targeting of Drosophila roX genes by the MSL dosage compensation complex

AU - Park, Yongkyu

AU - Mengus, Gabrielle

AU - Bai, Xiaoying

AU - Kageyama, Yuji

AU - Meller, Victoria H.

AU - Becker, Peter B.

AU - Kuroda, Mitzi I.

PY - 2003/4/1

Y1 - 2003/4/1

N2 - MSL complexes bind the single male X chromosome in Drosophila to increase transcription approximately 2-fold. Complexes contain at least five proteins and two noncoding RNAs, roX1 and roX2. The mechanism of X chromosome binding is not known. Here, we identify a 110 bp sequence in roX2 characterized by high-affinity MSL binding, male-specific DNase I hypersensitivity, a shared consensus with the otherwise dissimilar roX1 gene, and conservation across species. Mutagenesis of evolutionarily conserved sequences diminishes MSL binding in vivo. MSL binding to these sites is roX RNA dependent, suggesting that complexes become competent for binding only after incorporation of roX RNAs. However, the roX RNA segments homologous to the DNA binding sites are not required, ruling out simple RNA-DNA complementarity as the primary targeting mechanism. Our results are consistent with a model in which nascent roX RNA assembly with MSL proteins is an early step in the initiation of dosage compensation.

AB - MSL complexes bind the single male X chromosome in Drosophila to increase transcription approximately 2-fold. Complexes contain at least five proteins and two noncoding RNAs, roX1 and roX2. The mechanism of X chromosome binding is not known. Here, we identify a 110 bp sequence in roX2 characterized by high-affinity MSL binding, male-specific DNase I hypersensitivity, a shared consensus with the otherwise dissimilar roX1 gene, and conservation across species. Mutagenesis of evolutionarily conserved sequences diminishes MSL binding in vivo. MSL binding to these sites is roX RNA dependent, suggesting that complexes become competent for binding only after incorporation of roX RNAs. However, the roX RNA segments homologous to the DNA binding sites are not required, ruling out simple RNA-DNA complementarity as the primary targeting mechanism. Our results are consistent with a model in which nascent roX RNA assembly with MSL proteins is an early step in the initiation of dosage compensation.

UR - http://www.scopus.com/inward/record.url?scp=0037623368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037623368&partnerID=8YFLogxK

U2 - 10.1016/S1097-2765(03)00147-3

DO - 10.1016/S1097-2765(03)00147-3

M3 - Article

C2 - 12718883

AN - SCOPUS:0037623368

VL - 11

SP - 977

EP - 986

JO - Molecular Cell

JF - Molecular Cell

SN - 1097-2765

IS - 4

ER -